Analyst Ratings for Mast Therapeutics (MSTX)

MSTX Rating Summary

MSTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MSTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $3.00 (+408.5%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
10/3/2013 Canaccord Genuity New Coverage Buy
(N/A)
3.00
(N/A)
0.45 0.59 31.11% Details
6/25/2013 Piper Jaffray New Coverage Overweight
(N/A)
1.00
(N/A)
0.45 0.59 31.11% Details
Like MSTX Ratings? Also take a look at MRK, ANX

MSTX Ratings News